OBJECTIVE: To examine variables associated with bone mineral density (BMD) and vertebral deformities in women with rheumatoid arthritis (RA) from 3 northwest European countries. METHODS: Female patients were recruited from rheumatology clinics in Oslo, Norway; Truro, UK; and Amsterdam, The Netherlands (150 total, 50 per center, age 50-70 years, disease duration > or = 5 years). Demographic and clinical data were collected and BMD was measured by means of dual energy x-ray absorptiometry. Associations between demographic and clinical measures on the one hand and BMD and vertebral deformities on the other were investigated by single and multiple regression analyses. RESULTS: Body mass index (BMI), medication use, RA damage measures, and BMD differed significantly between the 3 centers. Overall, Norwegian patients had the lowest BMI, used more corticosteroids and anti-osteoporotic drugs, had lower joint damage measured by Larsen score, and lower BMD at both spine and hip. High age, low BMI, and high cumulative dose of corticosteroids (last 2 years) are related to low BMD. A high Larsen score was associated with low BMD at the hip. Larsen score was the independent determinant of vertebral deformities after correction for center, age, BMI, and BMD. CONCLUSION: Data from 3 countries on BMD and vertebral deformities in female patients aged 50-70 years with longstanding RA are presented, demonstrating an association between radiographic RA damage and low BMD and between radiographic RA damage and vertebral deformities.
OBJECTIVE: To examine variables associated with bone mineral density (BMD) and vertebral deformities in women with rheumatoid arthritis (RA) from 3 northwest European countries. METHODS: Female patients were recruited from rheumatology clinics in Oslo, Norway; Truro, UK; and Amsterdam, The Netherlands (150 total, 50 per center, age 50-70 years, disease duration > or = 5 years). Demographic and clinical data were collected and BMD was measured by means of dual energy x-ray absorptiometry. Associations between demographic and clinical measures on the one hand and BMD and vertebral deformities on the other were investigated by single and multiple regression analyses. RESULTS: Body mass index (BMI), medication use, RA damage measures, and BMD differed significantly between the 3 centers. Overall, Norwegian patients had the lowest BMI, used more corticosteroids and anti-osteoporotic drugs, had lower joint damage measured by Larsen score, and lower BMD at both spine and hip. High age, low BMI, and high cumulative dose of corticosteroids (last 2 years) are related to low BMD. A high Larsen score was associated with low BMD at the hip. Larsen score was the independent determinant of vertebral deformities after correction for center, age, BMI, and BMD. CONCLUSION: Data from 3 countries on BMD and vertebral deformities in female patients aged 50-70 years with longstanding RA are presented, demonstrating an association between radiographic RA damage and low BMD and between radiographic RA damage and vertebral deformities.
Authors: Jie Zhang; David T Redden; Gerald McGwin; Leigh F Callahan; Edwin A Smith; Graciela S Alarcón; Larry W Moreland; Désirée M van der Heijde; Elizabeth E Brown; Donna K Arnett; Ted R Mikuls; S Louis Bridges Journal: Arthritis Rheum Date: 2010-08
Authors: Joachim Böttcher; Alexander Pfeil; Anders Rosholm; Max-Ludwig Schäfer; Ansgar Malich; Alexander Petrovitch; Bettina Seidl; Gabriele Lehmann; Hans-Joachim Mentzel; Gert Hein; Gunter Wolf; Werner A Kaiser Journal: J Digit Imaging Date: 2006-09 Impact factor: 4.056
Authors: A Pfeil; J Böttcher; H J Mentzel; G Lehmann; M L Schäfer; A Kramer; A Petrovitch; B E Seidl; A Malich; G Hein; G Wolf; W A Kaiser Journal: Rheumatol Int Date: 2006-05-31 Impact factor: 2.631
Authors: Stephen R Pye; Tarnya Marshall; Karl Gaffney; Alan J Silman; Deborah P M Symmons; Terence W O'Neill Journal: BMC Musculoskelet Disord Date: 2010-05-28 Impact factor: 2.362
Authors: Alexander Pfeil; Julia Lippold; Thorsten Eidner; Gabriele Lehmann; Peter Oelzner; Diane M Renz; Andreas Hansch; Gunter Wolf; Gert Hein; Werner A Kaiser; Joachim Böttcher Journal: Rheumatol Int Date: 2008-09-12 Impact factor: 2.631
Authors: Ragnhild E Orstavik; Glenn Haugeberg; Till Uhlig; Petter Mowinckel; Jan A Falch; Johan I Halse; Tore K Kvien Journal: Osteoporos Int Date: 2004-06-12 Impact factor: 4.507